Forest Laboratories agreed to acquire Clinical Data, a specialty pharmaceutical company, for $1.2 billion. The transaction reflects a price of $30 per share in cash plus contingent consideration of up to $6 per share that may be paid upon achievement...

Learning from Recent FDA Warning Letters Related to Computer Validation and Part 11: With Clear Recommendations for Corrective and Preventive Actions. The new Part 11 regulation takes quite some time, but inspectors go out and focus inspections on computer...

Sanofi-Aventis has entered into a definitve agreement to buy Genzyme for $20.1bn in cash, in addition to future payments based on the performance of Genzyme’s experimental multiple sclerosis drug (alemtuzumab MS). LGC adds PRIMACYT in-vitro products,...

Merck & Co said a state court jury in New Jersey has given ruling in its favor in the Rosenberg case, discarding the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use. New England Biolabs expands PCR reagents...

Capsugel Acquires GSK’s Drug Delivery Technology Capsugel, an innovator in drug delivery systems, announced its acquisition of a novel dosage form developed by GSK Read more AndersonBrecon Opens North American Facility AndersonBrecon Clinical Services...

The US Food and Drug Administration (FDA) has designated Inhibitex’s investigation of INX-08189, a potent guanosine nucleotide polymerase inhibitor for the treatment of chronic hepatitis C viral (HCV) infection, as a fast track development program. Lucentis...

Protect Pharmaceutical, a New Jersey-based drug delivery and new product development company, has completed the sale of two patents and patents-applications related to pain drugs to German specialty pharmaceutical company Grunenthal. Lundbeck gets Cephalon...

Paladin takes over Tempra from Bristol Myers Squibb Paladin Labs has acquired Tempra line of products from Bristol Myers Squibb in Canada including both syrup and drop formulations, under an agreement signed between both the companies. Pfizer Q4 revenue...

Diabetes on the rise in USA. The CDC says more than 26 million Americans have Type 2 diabetes, and another 79 million have prediabetes. Those numbers are up from 2008, when 23.6 million had diabetes and 57 million had prediabetes. “These distressing...

High-dose clopidogrel shows no better effect than standard dose in post-PCI patients at high risk of clots. Compared to a standard dose of clopidogrel, a higher dose of the anti-clotting agent did not reduce mortality, heart attack or the formation of...

Boehringer Ingelheim to acquire Amgen Fremont California facility. Boehringer Ingelheim is set to take over Amgen’s rights in and substantially all assets at its Fremont Callifornia development and manufacturing facility. Ironwood Pharma,...

Boehringer, Eli Lilly to develop diabetes compounds. Boehringer Ingelheim and Eli Lilly and Company have entered into a global alliance to jointly develop and commercialise a portfolio of diabetes compounds currently in mid- and late-stage development. Amgen...